Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002. After successfully taking itraconazole, the patient developed peripheral neuropathy (tingling and loss of sensation) in the hands. After stopping itraconazole – persistent chest infections requiring antibiotics and prednisolone were common. The patient at this point had a high IgE level and positive RAST tests. Voriconazole was then prescribed – which has successfully treated the aspergillus infection – no steroids are required and the cough is greatly reduced with the patient feeling well. However an unfortunate side effect of voriconazole has been a photosensitive rash on any exposed skin. Despite using complete sunscreen – the rash continues. The patient is continuing to take voriconazole.
Share this post
Latest News posts
How to use nebulised amphotericin
January 29, 2019
David Haussler: What Can We Learn From Sequencing Our Genomes?
January 29, 2019
Interview with CPA patient
January 29, 2019
Open the windows Poetry & Medicine
January 29, 2019
Bridging the Health Divide in Europe
January 29, 2019
Translational Medicine in Respiratory Disease
January 29, 2019
ERS Vision – Personalising Respiratory Care in Europe
January 29, 2019
Nutritional Science in the Prevention & Management of COPD
January 29, 2019
Designing Drugs to Better Help Real Lives
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video